curriculum vitae
... conjunction with clinical information. Responsible for building and implementing a web portal with the architecture behind it to merge clinical and mechanistic data in real time and allow interactive querying, sorting and graphing as well as more complex visualization tools. This is a large collabor ...
... conjunction with clinical information. Responsible for building and implementing a web portal with the architecture behind it to merge clinical and mechanistic data in real time and allow interactive querying, sorting and graphing as well as more complex visualization tools. This is a large collabor ...
Pharmaceutical Dosage Forms
... Pharmaceutical dosage form • Pharmaceutical dosage form – Determines the physical form of the final pharmaceutical preparation – Is a drug delivery system which is formed by technological processing (drug formulation) – Must reflect therapeutic intentions, route of ...
... Pharmaceutical dosage form • Pharmaceutical dosage form – Determines the physical form of the final pharmaceutical preparation – Is a drug delivery system which is formed by technological processing (drug formulation) – Must reflect therapeutic intentions, route of ...
Addiction as a Disease PowerPoint Slides
... amount that is harmful or potentially harmful • Drug addiction – compulsive use of hard drug in the presence of harm (psychological, physical or social) • Drug dependence – when one needs the drug to avoid withdrawal state or to maintain functional status ...
... amount that is harmful or potentially harmful • Drug addiction – compulsive use of hard drug in the presence of harm (psychological, physical or social) • Drug dependence – when one needs the drug to avoid withdrawal state or to maintain functional status ...
The buccal/sublingual route
... This route describes drug administration by injection such as •Intravenous route (i.v.): Very fast onset of action. •Subcutaneous route (s.c.): The easiest and least painful type of injection to administer. •Intramuscular route (i.m.): The drug can be formulated in an aqueous solution (fast onset), ...
... This route describes drug administration by injection such as •Intravenous route (i.v.): Very fast onset of action. •Subcutaneous route (s.c.): The easiest and least painful type of injection to administer. •Intramuscular route (i.m.): The drug can be formulated in an aqueous solution (fast onset), ...
TOXICOLOGY – TEST 1 STUDY GUIDE
... Solubility of the drug – the more soluble the drug, the faster it can be absorbed Drug interactions – the more interactions the drug has, the slower the absorption pH – some drugs are absorbed faster than others in higher/lower pH’s. Definitions - Bioavailability – this is the part/amount of t ...
... Solubility of the drug – the more soluble the drug, the faster it can be absorbed Drug interactions – the more interactions the drug has, the slower the absorption pH – some drugs are absorbed faster than others in higher/lower pH’s. Definitions - Bioavailability – this is the part/amount of t ...
PHARMACY BENEFIT UPDATE Preferred Drug List
... DUR will seek to promote a thoughtful discussion to identify reasons these high-risk patients are not utilizing high–intensity statins. Please look for these provider letters in the coming weeks. G. Antipyschotic Utilization in Children Back in the summer of 2012, MaineCare and the DUR Committee rev ...
... DUR will seek to promote a thoughtful discussion to identify reasons these high-risk patients are not utilizing high–intensity statins. Please look for these provider letters in the coming weeks. G. Antipyschotic Utilization in Children Back in the summer of 2012, MaineCare and the DUR Committee rev ...
FORM – Initial Review - UIC Office of the Vice Chancellor for Research
... 2. If an IND is required, please attach one of the following to allow verification of the IND number: IND approval letter from FDA, IND number printed in sponsor’s protocol, or letter from sponsor. 3. If the investigator is the IND holder (sponsor), please attach a copy of the IND approval letter fr ...
... 2. If an IND is required, please attach one of the following to allow verification of the IND number: IND approval letter from FDA, IND number printed in sponsor’s protocol, or letter from sponsor. 3. If the investigator is the IND holder (sponsor), please attach a copy of the IND approval letter fr ...
HEMATEMESIS AND GI BLOOD LOSS Michael D Willard
... not true with all types of ulcers (e.g., they are not effective in preventing ulcers due to NSAIDs or due to steroids). Proton pump inhibitors are the most effective antacid drugs we have. Omeprazole, lansoprazole and pantoprazole are the most effective inhibitors of gastric acid secretion we curren ...
... not true with all types of ulcers (e.g., they are not effective in preventing ulcers due to NSAIDs or due to steroids). Proton pump inhibitors are the most effective antacid drugs we have. Omeprazole, lansoprazole and pantoprazole are the most effective inhibitors of gastric acid secretion we curren ...
CI Drugs 2
... supposedly lead to abuse of other substances. Marijuana, for instance, is considered by some to be a gateway to harder drugs. Basically, this concept says that if you abuse drugs like marijuana you will be more likely to be open to the use of harder drugs like cocaine and heroin ...
... supposedly lead to abuse of other substances. Marijuana, for instance, is considered by some to be a gateway to harder drugs. Basically, this concept says that if you abuse drugs like marijuana you will be more likely to be open to the use of harder drugs like cocaine and heroin ...
October 2012 - Kaiser Permanente
... o Kaiser Permanente has a rigorous process for approving compounding vendors and only contract with a select number of compounding pharmacies The Centers for Disease Control and Prevention (CDC) is working with the New England Compounding Center to contact patients who were potentially infected ...
... o Kaiser Permanente has a rigorous process for approving compounding vendors and only contract with a select number of compounding pharmacies The Centers for Disease Control and Prevention (CDC) is working with the New England Compounding Center to contact patients who were potentially infected ...
Psychopharmacology and Other Biologic Treatments
... blood brain barrier (then, can also pass through placenta) ...
... blood brain barrier (then, can also pass through placenta) ...
Management of overdose and poisoning
... lactic acidosis- renal failure 25% - death Stage IV (4 days to 2 weeks) Recovery phase that usually begins by day 4 and is complete by 7 days after overdose ...
... lactic acidosis- renal failure 25% - death Stage IV (4 days to 2 weeks) Recovery phase that usually begins by day 4 and is complete by 7 days after overdose ...
Issues of - AETC-NMC
... A polymorphism in the HLA-B genetic locus (HLA-B*5701) was found associated with abacavir hypersensitiviy in whites and Latinos, but in African-Americans, initial studies found it alone lacked sufficient predictive value to identify patients at risk (Hughes, et al., Pharmacogenomics. 2004 Mar;5(2):2 ...
... A polymorphism in the HLA-B genetic locus (HLA-B*5701) was found associated with abacavir hypersensitiviy in whites and Latinos, but in African-Americans, initial studies found it alone lacked sufficient predictive value to identify patients at risk (Hughes, et al., Pharmacogenomics. 2004 Mar;5(2):2 ...
FORMULATION AND EVALUATION OF VINPOCETINE LOADED LIPOSPHERES Research Article
... study it also seen that formulation F1 has waxy appearance and yield was not good, F2 has yield problem and poor release, by F5 lipospheres was not formed only hazy solution was appear, F6 shows poor release and F7 has also poor yield. So it is concluded that best lipospheres were prepared by bees w ...
... study it also seen that formulation F1 has waxy appearance and yield was not good, F2 has yield problem and poor release, by F5 lipospheres was not formed only hazy solution was appear, F6 shows poor release and F7 has also poor yield. So it is concluded that best lipospheres were prepared by bees w ...
NURS 1011-Pharmacology I Online Syllabus
... 16. I copy notes form the instructor’s PowerPoint slides, but later it seems like I am missing information. 17. My mind wanders in class and I don’t hear what the instructor says. 18. My instructor talks too fast and there is no way I can keep up with my notes. 19. The instructor mostly reads or rep ...
... 16. I copy notes form the instructor’s PowerPoint slides, but later it seems like I am missing information. 17. My mind wanders in class and I don’t hear what the instructor says. 18. My instructor talks too fast and there is no way I can keep up with my notes. 19. The instructor mostly reads or rep ...
Volume 6 Number 18 (Issue 195) Tuesday, Jul yy 22,, 2008 NEW
... they can be easily read.” The term is attributed to pharmacist Tom Genco of New Jersey. It is in reference to electronic prescriptions (e-prescribing) where the prescription is printed out (avoiding the scribble problem) but still may contain errors, as any other prescription may. The lesson is that ...
... they can be easily read.” The term is attributed to pharmacist Tom Genco of New Jersey. It is in reference to electronic prescriptions (e-prescribing) where the prescription is printed out (avoiding the scribble problem) but still may contain errors, as any other prescription may. The lesson is that ...
SUSTAINED RELAEASE MULTIPARTICULATE DRUG DELIVERY
... Ideally, a drug should arrive rapidly at the site of action in the optimum concentration, remain for the desired time, be excluded from other sites, and be rapidly removed when the goal is achieved. However, where highly water-soluble drugs are concerned, formulation into a dosage form is tricky and ...
... Ideally, a drug should arrive rapidly at the site of action in the optimum concentration, remain for the desired time, be excluded from other sites, and be rapidly removed when the goal is achieved. However, where highly water-soluble drugs are concerned, formulation into a dosage form is tricky and ...
Inturrisi), Weill Cornell Medical College, New York, New York
... Agency Medical Directors, is to use validated tools to track change in function and pain level in patients using opioids.3 In this way, we can learn whether our patients are benefiting from long-term opioid use, not only in reported pain level, but in their ability to function in their daily lives. ...
... Agency Medical Directors, is to use validated tools to track change in function and pain level in patients using opioids.3 In this way, we can learn whether our patients are benefiting from long-term opioid use, not only in reported pain level, but in their ability to function in their daily lives. ...
gravlactbase
... • Once daily administration: take the drug immediately after (or immediately before) breastfeeding followed by the longest time between feedings (usually the night). • More than once-a-day administration: take the drug immediately before or (immediately after) breastfeeding. • In most cases, avoidin ...
... • Once daily administration: take the drug immediately after (or immediately before) breastfeeding followed by the longest time between feedings (usually the night). • More than once-a-day administration: take the drug immediately before or (immediately after) breastfeeding. • In most cases, avoidin ...
Introduction - Biomolecular Engineering Laboratory
... anticancer agents screening of 35,000 plants • 1967 : Identification of cytotoxic ingredient from the bark of Pacific yew tree Taxol (Generic name) • 1969 : 10 g of pure compound from 1,200 kg of bark • 1979 : Mechanism of action in leukamic mice inhibition of cell division by stabilization of ...
... anticancer agents screening of 35,000 plants • 1967 : Identification of cytotoxic ingredient from the bark of Pacific yew tree Taxol (Generic name) • 1969 : 10 g of pure compound from 1,200 kg of bark • 1979 : Mechanism of action in leukamic mice inhibition of cell division by stabilization of ...
Bad Pharma
.JPG?width=300)
Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients is a book by British physician and academic Ben Goldacre about the pharmaceutical industry, its relationship with the medical profession, and the extent to which it controls academic research into its own products. The book was published in September 2012 in the UK by the Fourth Estate imprint of HarperCollins, and in February 2013 in the United States by Faber and Faber.Goldacre argues in the book that ""the whole edifice of medicine is broken"" because the evidence on which it is based is systematically distorted by the pharmaceutical industry. He writes that the industry finances most of the clinical trials into its own products and much of doctors' continuing education, that clinical trials are often conducted on small groups of unrepresentative subjects and negative data is routinely withheld, and that apparently independent academic papers may be planned and even ghostwritten by pharmaceutical companies or their contractors, without disclosure. Goldacre calls the situation a ""murderous disaster,"" and makes suggestions for action by patients' groups, physicians, academics and the industry itself.Responding to the book's publication, the Association of the British Pharmaceutical Industry issued a statement arguing that the examples the book offers are historical, that the concerns have been addressed, that the industry is among the most regulated in the world, and that it discloses all data in accordance with international standards.In January 2013 Goldacre joined the Cochrane Collaboration, British Medical Journal and others in setting up AllTrials, a campaign calling for the results of all past and current clinical trials to be reported. The British House of Commons Public Accounts Committee expressed concern in January 2014 that drug companies were still only publishing around 50 percent of clinical-trial results.